Back to funds

Caligan Partners LP

Updated 6 days ago

Managed by Caligan Partners Lp • Latest filing Q3 2026

Portfolio value
$1.6B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.2B
Q1 2026$1.5B
Q2 2026$2.1B
Q3 2026$1.6B

Top holdings

26 positions as of Q3 2026

View filing
R

REVOLUTION MEDICINES INC

Value
$402.7M
Shares
1.96M
% Port
24.64%
L

LIQUIDIA CORPORATION

Value
$245.7M
Shares
8.12M
% Port
15.03%
A

ABIVAX SA

Value
$154.3M
Shares
1.56M
% Port
9.44%
P

VAXCYTE INC

Value
$124.5M
Shares
2.19M
% Port
7.62%
E

EXELIXIS INC

Value
$90.7M
Shares
1.55M
% Port
5.55%
T

TANGO THERAPEUTICS INC

Value
$62.4M
Shares
2.50M
% Port
3.82%
A

ADMA BIOLOGICS INC

Value
$58.9M
Shares
5.88M
% Port
3.61%
I

IMMUNOCORE HLDGS PLC

Value
$50.6M
Shares
1.67M
% Port
3.10%
A

AVALO THERAPEUTICS INC

Value
$50.1M
Shares
3.27M
% Port
3.07%
L

LB PHARMACEUTICALS INC

Value
$49.6M
Shares
1.51M
% Port
3.04%
V

VIRIDIAN THERAPEUTICS INC

Value
$45.2M
Shares
2.19M
% Port
2.76%
V

VOR BIOPHARMA INC

Value
$36.7M
Shares
1.93M
% Port
2.25%
I

INVENTIVA SA

Value
$33.9M
Shares
9.19M
% Port
2.07%
I

OPUS GENETICS INC

Value
$28.9M
Shares
5.96M
% Port
1.77%
A

AURA BIOSCIENCES INC

Value
$28.8M
Shares
4.59M
% Port
1.76%
A

ANIKA THERAPEUTICS INC

Value
$28.2M
Shares
1.44M
% Port
1.73%
S

SAB BIOTHERAPEUTICS INC

Value
$27.7M
Shares
8.74M
% Port
1.69%
S

SAGIMET BIOSCIENCES INC

Value
$27.6M
Shares
2.79M
% Port
1.69%
F

FAETH THERAPEUTICS INC

Value
$26.5M
Shares
890.2K
% Port
1.62%
T

TYRA BIOSCIENCES INC

Value
$19.9M
Shares
910.7K
% Port
1.22%

Explore